ProKidney Corp.

A pioneer in the treatment of chronic kidney diseases (CKD) through innovations in cellular therapy.

[ProKidney Corp. @ProKidney]

"The kidney isn't one target. It's really dozens of highly specialized targets packed into one organ." Our CEO joined @biospace's Denatured to discuss what that means for cell and gene therapy in #KidneyDisease. https://t.co/2uP8rm9KaJ

#CKD #CellTherapy #GeneTherapy

[ProKidney Corp. @ProKidney]

Our final #KidneyWk posters will be presented this morning, including two that follow rilparencel, our investigational cell therapy, through manufacturing. Thank you to everyone who has stopped by this week.

[ProKidney Corp. @ProKidney]

Leading clinical researcher Katherine Tuttle, MD, joins CEO Bruce Culleton, MD + R&D Head Anthony Conway, PhD, to discuss new research on our investigational cell therapy, and the evolving #CKD treatment landscape. Live Q&A will follow. Register: https://t.co/XNYvLUx8fE

[ProKidney Corp. @ProKidney]

Today at #KidneyWk: a pooled Phase 2 analysis and a manufacturing poster this morning (10 AM–12 PM MDT), then our oral presentation at 5:40 PM in Mile High Ballroom 1D.

[ProKidney Corp. @ProKidney]

Our first two #KidneyWk posters will be presented this morning, both on studying CKD in human cells and tissue outside the body. Our team is at TH-PO1128 and TH-PO1129 until noon MDT.

[ProKidney Corp. @ProKidney]

We’re heading to Denver for @ASNKidney #KidneyWk to share new research on rilparencel, our investigational autologous cell therapy, including non-clinical research and a pooled analysis from our Phase 2 studies. Learn more ↓

[ProKidney Corp. @ProKidney]

How might cell therapy work in CKD? At #KidneyWk, we’ll share 8 abstracts exploring that question, from non-clinical CKD models, drug product characterization, and more. https://t.co/ICZs637774

#CKD #CellTherapy

[ProKidney Corp. @ProKidney]

For people with advanced #CKD, the biggest threat is often cardiovascular disease, not kidney failure. On #WorldHeartDay, we're recognizing the close connection between heart and kidney health.
#KidneyHealth

[ProKidney Corp. @ProKidney]

The risk factors highlighted during #CholesterolEducationMonth, including diabetes, high blood pressure and metabolic disease, are also leading drivers of #CKD. Because CKD often develops without symptoms, many people don't know they have it. Learn more: https://t.co/91R5vtQSBe

[ProKidney Corp. @ProKidney]

Our Boston team assembled nutritional starter kits for CKD patients across New England — recipe cards, measuring spoons, jar openers, educational materials and more. Thanks to @NKFNewEngland for bringing the ingredients and for everything they do for #CKD patients. #KidneyHealth

[ProKidney Corp. @ProKidney]

Orange pom-poms, catch on the field, and Sidney the Kidney. Thanks to @WSDashBaseball and @nkfcarolinas for a great Sunday at Truist Stadium, and for the kidney health resources they shared with fans all afternoon. #KidneyHealth #WinstonSalem

[ProKidney Corp. @ProKidney]

Dialysis often means three to four hours in a chair, three times a week, then feeling too exhausted to work. On the Vanguards of Health Care podcast, our CEO on why ProKidney focuses on preserving kidney function. https://t.co/n2dGMnBohH

#CKD #KidneyHealth

[ProKidney Corp. @ProKidney]

Sunday Fun Day at Truist Stadium this weekend. Our team will be there with @WSDashBaseball and @nkfcarolinas, who’ll be there with kidney health resources on site. A portion from every ticket purchased through their link supports NKF’s work in NC.

#KidneyHealth #WinstonSalem

[ProKidney Corp. @ProKidney]

#CKD therapies like SGLT2 inhibitors, finerenone and GLP-1 RAs have given patients more ways to slow progression. Rilparencel, our investigational cell therapy, is being studied as a potential addition.

[ProKidney Corp. @ProKidney]

Today is National Patient Advocacy Day. In kidney care, advocates help patients understand their options, find resources and make their voices heard. So much in #CKD is learned from patients themselves. To everyone standing alongside them, thank you. #KidneyHealth

[ProKidney Corp. @ProKidney]

August is National Minority Donor Awareness Month. More than 100,000 people in the US are waiting for a transplant, and 60% are from racial and ethnic minority communities. A reminder of why registration and equitable access matter. #KidneyHealth

[ProKidney Corp. @ProKidney]

New on @BBGIntelligence's Vanguards of Health Care: our CEO Bruce Culleton, MD on advanced #CKD, why patients still progress despite better care and how rilparencel, our investigational cell therapy, aims to preserve function. https://t.co/n2dGMnBohH

[ProKidney Corp. @ProKidney]

Big moment for our team: a group of well-deserved promotions across ProKidney. 👏

These are the people turning bold science into real progress for patients with advanced CKD and type 2 diabetes — and raising the bar every step of the way.
#TeamProKidney #BiotechCareers

[ProKidney Corp. @ProKidney]

Most #CKD therapies aim to slow progression. Rilparencel, our investigational cell therapy, takes a different approach, using a patient’s own kidney cells to help preserve function. Learn more about our clinical trial: https://t.co/CQA9KdDY4A

#ClinicalTrials #KidneyHealth

[ProKidney Corp. @ProKidney]

This #ChronicDiseaseDay: chronic kidney disease is one of the most common chronic conditions, affecting millions of Americans. In advanced #CKD, the goal is preserving kidney function, which drives the work we do every day.

Learn more: https://t.co/ZTxOlxpl9c